TY  - JOUR
AU  - Pérez-Cantero, Alba
AU  - Serrano López, Dolores Remedios
AU  - Navarro Rodríguez, Patricia
AU  - Schätzlein, Andreas G.
AU  - Uchegbu, Ijeoma F.
AU  - Torrado Durán, Juan José
AU  - Capilla, Javier
PY  - 2019
DO  - 10.3390/pharmaceutics11090456
SN  - 1999-4923
UR  - https://hdl.handle.net/20.500.14352/12753
T2  - Pharmaceutics
AB  - Invasive pulmonary aspergillosis represents one of the most serious fungal infections among immunocompromised patients. In this study, we aimed to analyze the in vivo e_cacy of prophylactic oral amphotericin B (AMB) encapsulated in modified...
LA  - eng
M2  - 456
PB  - MDPI
KW  - Aspergillosis
KW  - Amphotericin B
KW  - Oral delivery
KW  - Chitosan
KW  - shiitake
KW  - Lentinula edodes
KW  - AHCC®
KW  - Molecular Envelope Technology
TI  - Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis
TY  - journal article
VL  - 11
ER  -